These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8895780)

  • 21. Protective immunity evoked by synthetic peptides of streptococcal M proteins.
    Beachey EH
    Adv Exp Med Biol; 1985; 185():193-200. PubMed ID: 2416199
    [No Abstract]   [Full Text] [Related]  

  • 22. Group A streptococcus vaccine may be ready for phase I clinical trials in late 1989.
    Raymond CA
    JAMA; 1988 Nov; 260(19):2778. PubMed ID: 3054182
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenicity of a polypeptide fragment of the streptococcal group A M protein conjugated with an acrylic acid N-vinylpyrrolidone copolymer.
    Lyampert IM; Semenova EN; Sanina VYu ; Puchkova NG; Nekrasov AV
    Biomed Sci; 1991; 2(4):410-4. PubMed ID: 1797145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions.
    Fischetti VA; Bessen DE; Schneewind O; Hruby DE
    Adv Exp Med Biol; 1991; 303():159-67. PubMed ID: 1805563
    [No Abstract]   [Full Text] [Related]  

  • 25. Group A streptococcus epidemiology and vaccine implications.
    Cohen-Poradosu R; Kasper DL
    Clin Infect Dis; 2007 Oct; 45(7):863-5. PubMed ID: 17806050
    [No Abstract]   [Full Text] [Related]  

  • 26. The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.
    Smeesters PR; Dramaix M; Van Melderen L
    Vaccine; 2010 Jan; 28(4):883-5. PubMed ID: 19963033
    [No Abstract]   [Full Text] [Related]  

  • 27. Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model.
    McArthur J; Medina E; Mueller A; Chin J; Currie BJ; Sriprakash KS; Talay SR; Chhatwal GS; Walker MJ
    Infect Immun; 2004 Dec; 72(12):7342-5. PubMed ID: 15557665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial adherence: the attachment of group A streptococci to mucosal surfaces.
    Beachey EH; Courtney HS
    Rev Infect Dis; 1987; 9 Suppl 5():S475-81. PubMed ID: 3317744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections.
    The Editors
    J Med Microbiol; 2000 Oct; 49(10):849-852. PubMed ID: 11023181
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp-2 tissue culture cells.
    Courtney HS; Dale JB; Hasty DI
    Infect Immun; 1996 Jul; 64(7):2415-9. PubMed ID: 8698460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on streptococcal prevalence in Chiang Mai, Thailand, with special reference to unusual combination between T and M antigens of group A Streptococcus].
    Murai T; Inazumi Y; Pruksakorn S
    Kansenshogaku Zasshi; 1988 Oct; 62(10):869-77. PubMed ID: 3145307
    [No Abstract]   [Full Text] [Related]  

  • 32. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiologic profile of streptococcal infections in collectivities of children followed over a sixteen year period.
    Măgureanu E; Dobrescu A; Horhogea G; Ulmeanu V; Grigoriu T; Debeleac L; Ionescu M; Ionescu E; Zolotovschi JC
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):375-84. PubMed ID: 6761392
    [No Abstract]   [Full Text] [Related]  

  • 34. Streptococcal M protein.
    Fischetti VA
    Sci Am; 1991 Jun; 264(6):58-65. PubMed ID: 1857955
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci.
    Courtney HS; Hasty DL; Dale JB
    Ann Med; 2002; 34(2):77-87. PubMed ID: 12108578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a fibronectin-binding protein as adhesin of Streptococcus pyogenes.
    Valentin-Weigand P; Talay SR; Timmis KN; Chhatwal GS
    Zentralbl Bakteriol; 1993 Apr; 278(2-3):238-45. PubMed ID: 8347928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between elevated serum antibody levels to streptococcal M12 protein and susceptibility to dermatomyositis.
    Ichimiya M; Yasui H; Hirota Y; Ohmura A; Muto M
    Arch Dermatol Res; 1998 Apr; 290(4):229-30. PubMed ID: 9617445
    [No Abstract]   [Full Text] [Related]  

  • 38. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to superoxide dismutase in group A streptococcal infection.
    McMillan DJ; Davies MR; Good MF; Sriprakash KS
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):249-56. PubMed ID: 15039102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice.
    Kawabata S; Kunitomo E; Terao Y; Nakagawa I; Kikuchi K; Totsuka K; Hamada S
    Infect Immun; 2001 Feb; 69(2):924-30. PubMed ID: 11159987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.